n-(2-hydroxypropyl)methacrylamide has been researched along with pyropheophorbide a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Etrych, T; Fang, J; Hackbarth, S; Islam, R; Islam, W; Maeda, H; Šubr, V; Ulbrich, K | 1 |
| Dai, X; Duan, Z; Gong, Q; Gu, L; Gu, Z; Li, X; Luo, K; Luo, Q; Tian, X; Zhang, H; Zhu, H | 1 |
2 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and pyropheophorbide a
| Article | Year |
|---|---|
N-(2-hydroxypropyl)methacrylamide polymer conjugated pyropheophorbide-a, a promising tumor-targeted theranostic probe for photodynamic therapy and imaging.
Topics: Animals; Chlorophyll; Fluorescence; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Micelles; Particle Size; Permeability; Photochemotherapy; Photosensitizing Agents; Polymers; Polymethacrylic Acids; Theranostic Nanomedicine; Time Factors; Tissue Distribution | 2018 |
Synergistic Therapy of a Naturally Inspired Glycopolymer-Based Biomimetic Nanomedicine Harnessing Tumor Genomic Instability.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomimetic Materials; Cell Line, Tumor; Chlorophyll; DNA Damage; Drug Carriers; Genomic Instability; Humans; Light; Mice; Nanomedicine; Nanostructures; Neoplasms; Photochemotherapy; Phthalazines; Piperazines; Polymethacrylic Acids; Polysaccharides; Reactive Oxygen Species | 2021 |